The peroxisomal transporter ABCD3 plays a major role in dicarboxylic fatty acid metabolism

Peroxisomes metabolize a specific subset of fatty acids, which include dicarboxylic fatty acids (DCAs) generated by ω-oxidation. Data obtained in vitro suggest that the peroxisomal transporter ABCD3 (also known as PMP70) mediates the transport of DCAs into the peroxisome, but in vivo evidence to support this role is lacking. In this study, we studied an Abcd3 KO mouse model generated by CRISPR-Cas9 technology using targeted and untargeted metabolomics, histology, immunoblotting, and stable isotope tracing technology. We show that ABCD3 functions in DCA metabolism and uncover a novel role for this peroxisomal transporter in lipid metabolic homeostasis. The Abcd3 KO mouse presents with lipodystrophy, increased circulating free fatty acids, decreased ketone bodies, enhanced hepatic cholesterol synthesis and decreased hepatic de novo lipogenesis. Moreover, our study suggests that DCAs are metabolized by mitochondrial β-oxidation when ABCD3 is not functional, reflecting the importance of the metabolic compartmentalization and communication between peroxisomes and mitochondria. In summary, this study provides data on the role of the peroxisomal transporter ABCD3 in hepatic lipid homeostasis and DCA metabolism, and the consequences of peroxisomal dysfunction for the liver.

[1]  C. Argmann,et al.  Deficiency of peroxisomal L-bifunctional protein (EHHADH) causes male-specific kidney hypertrophy and proximal tubular injury in mice , 2021, bioRxiv.

[2]  S. Friedman,et al.  Murine deficiency of peroxisomal l-bifunctional protein (EHHADH) causes medium-chain 3-hydroxydicarboxylic aciduria and perturbs hepatic cholesterol homeostasis , 2021, Cellular and Molecular Life Sciences.

[3]  H. Waterham,et al.  Peroxisomal Metabolite and Cofactor Transport in Humans , 2021, Frontiers in Cell and Developmental Biology.

[4]  F. Vaz,et al.  Slc22a5 haploinsufficiency does not aggravate the phenotype of the long‐chain acyl‐CoA dehydrogenase KO mouse , 2019, Journal of inherited metabolic disease.

[5]  C. Argmann,et al.  Peroxisomes can oxidize medium‐ and long‐chain fatty acids through a pathway involving ABCD3 and HSD17B4 , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[7]  Michael F. Wangler,et al.  A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers , 2018, Genetics in Medicine.

[8]  Steve D. M. Brown,et al.  High-throughput discovery of novel developmental phenotypes , 2017 .

[9]  M. Baes,et al.  Hepatic dysfunction in peroxisomal disorders. , 2016, Biochimica et biophysica acta.

[10]  Marc Engelen,et al.  Zellweger spectrum disorders: clinical overview and management approach , 2015, Orphanet Journal of Rare Diseases.

[11]  J. Kelleher,et al.  Compartmentation of Metabolism of the C12-, C9-, and C5-n-dicarboxylates in Rat Liver, Investigated by Mass Isotopomer Analysis , 2015, The Journal of Biological Chemistry.

[12]  Adam D. Kennedy,et al.  Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism , 2015, Journal of Inherited Metabolic Disease.

[13]  A. Moser,et al.  A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3. , 2015, Human molecular genetics.

[14]  H. Waterham,et al.  A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids. , 2014, Biochimica et biophysica acta.

[15]  W. Wahli,et al.  The peroxisomal enzyme L-PBE is required to prevent the dietary toxicity of medium-chain fatty acids. , 2013, Cell reports.

[16]  R. Wanders,et al.  Characterization of D-3-hydroxybutyrylcarnitine (ketocarnitine): an identified ketosis-induced metabolite. , 2012, Metabolism: clinical and experimental.

[17]  C. Argmann,et al.  Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids , 2012, Journal of Lipid Research.

[18]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[19]  F. Theodoulou,et al.  Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance , 2011, British journal of pharmacology.

[20]  P. Carmeliet,et al.  Carbohydrate Metabolism Is Perturbed in Peroxisome-deficient Hepatocytes Due to Mitochondrial Dysfunction, AMP-activated Protein Kinase (AMPK) Activation, and Peroxisome Proliferator-activated Receptor γ Coactivator 1α (PGC-1α) Suppression* , 2011, The Journal of Biological Chemistry.

[21]  J. Swinnen,et al.  Hepatosteatosis in peroxisome deficient liver despite increased β-oxidation capacity and impaired lipogenesis. , 2011, Biochimie.

[22]  Jianguo Xia,et al.  Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst , 2011, Nature Protocols.

[23]  Stephen F Previs,et al.  Triglyceride Synthesis in Epididymal Adipose Tissue , 2009, Journal of Biological Chemistry.

[24]  E. Ver Loren van Themaat,et al.  Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice. , 2008, Biochimica et biophysica acta.

[25]  R. Wanders,et al.  Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation. , 2008, Molecular genetics and metabolism.

[26]  A. Moser,et al.  Clinical, biochemical, and mutational spectrum of peroxisomal acyl–coenzyme A oxidase deficiency , 2007, Human mutation.

[27]  J. Reddy,et al.  Beta-oxidation in hepatocyte cultures from mice with peroxisomal gene knockouts. , 2007, Biochemical and biophysical research communications.

[28]  C. Hoppel,et al.  Probing peroxisomal β-oxidation and the labelling of acetyl-CoA proxies with [1-13C]octanoate and [3-13C]octanoate in the perfused rat liver , 2005 .

[29]  S. Ferdinandusse,et al.  Developmental Changes of Bile Acid Composition and Conjugation in L- and D-Bifunctional Protein Single and Double Knockout Mice* , 2005, Journal of Biological Chemistry.

[30]  Ilse Vanhorebeek,et al.  Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities , 2005, Hepatology.

[31]  R. Wanders,et al.  Characterization of carnitine and fatty acid metabolism in the long-chain acyl-CoA dehydrogenase-deficient mouse. , 2005, The Biochemical journal.

[32]  S. Ferdinandusse,et al.  Identification of the peroxisomal β-oxidation enzymes involved in the degradation of long-chain dicarboxylic acids Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.M300512-JLR200 , 2004, Journal of Lipid Research.

[33]  Ronald J A Wanders,et al.  Phosphomevalonate kinase is a cytosolic protein in humans Published, JLR Papers in Press, January 16, 2004. DOI 10.1194/jlr.M300373-JLR200 , 2004, Journal of Lipid Research.

[34]  David Millington,et al.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.

[35]  Ronald J A Wanders,et al.  Mevalonate kinase is a cytosolic enzyme in humans , 2004, Journal of Cell Science.

[36]  P. Vreken,et al.  Rapid analysis of conjugated bile acids in plasma using electrospray tandem mass spectrometry: Application for selective screening of peroxisomal disorders , 1999, Journal of Inherited Metabolic Disease.

[37]  V. Chandramouli,et al.  Influence of diet on the modeling of adipose tissue triglycerides during growth. , 2003, American journal of physiology. Endocrinology and metabolism.

[38]  R. Wanders,et al.  Characteristic Acylcarnitine Profiles in Inherited Defects of Peroxisome Biogenesis: A Novel Tool for Screening Diagnosis Using Tandem Mass Spectrometry , 2003, Pediatric Research.

[39]  B. Poll-The,et al.  Phytanic and pristanic acid are naturally occuring ligands. , 2003, Advances in experimental medicine and biology.

[40]  F. Wouters,et al.  Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carrier protein-2/sterol carrier protein-x gene function. , 1998, Genes & development.

[41]  J. Reddy,et al.  Hepatocellular and Hepatic Peroxisomal Alterations in Mice with a Disrupted Peroxisomal Fatty Acyl-coenzyme A Oxidase Gene* , 1996, The Journal of Biological Chemistry.

[42]  M. Pourfarzam,et al.  Skeletal muscle mitochondrial β-oxidation of dicarboxylates , 1993 .

[43]  M. Pourfarzam,et al.  Skeletal muscle mitochondrial beta-oxidation of dicarboxylates. , 1993, Biochimica et biophysica acta.

[44]  K. Tserng,et al.  Metabolic conversion of dicarboxylic acids to succinate in rat liver homogenates. A stable isotope tracer study. , 1991, The Journal of biological chemistry.

[45]  M. Pourfarzam,et al.  Products and intermediates of the beta-oxidation of [U-14C]hexadecanedionoyl-mono-CoA by rat liver peroxisomes and mitochondria. , 1991, The Biochemical journal.

[46]  T. Hashimoto,et al.  The 70-kDa peroxisomal membrane protein is a member of the Mdr (P-glycoprotein)-related ATP-binding protein superfamily. , 1990, The Journal of biological chemistry.

[47]  F. Leighton,et al.  Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation. , 1989, The Journal of biological chemistry.

[48]  H. Moser,et al.  Peroxisomal L-Pipecolic Acid Oxidation Is Deficient in Liver from Zellweger Syndrome Patients , 1989, Pediatric Research.

[49]  T. Watanabe,et al.  Compartmentation of dicarboxylic acid beta-oxidation in rat liver: importance of peroxisomes in the metabolism of dicarboxylic acids. , 1989, Biochimica et biophysica acta.

[50]  F. Gonzalez,et al.  Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LA omega). Identification of a new cytochrome P-450 gene family. , 1987, The Journal of biological chemistry.

[51]  S. Kolvraa,et al.  In vitro studies on the oxidation of medium-chain dicarboxylic acids in rat liver. , 1986, Biochimica et biophysica acta.

[52]  P. Bougnères,et al.  Medium- and Long-Chain Dicarboxylic Aciduria in Patients with Zellweger Syndrome and Neonatal Adrenoleukodystrophy , 1986, Pediatric Research.

[53]  G. Getz,et al.  Effect of Reye's syndrome serum on isolated chinchilla liver mitochondria. , 1985, The Journal of clinical investigation.

[54]  S. Passi,et al.  Antimitochondrial effect of saturated medium chain length (C8-C13) dicarboxylic acids. , 1984, Biochemical pharmacology.

[55]  T. P. Krishnakantha,et al.  Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate , 1975, Science.

[56]  J. E. Pettersen In vitro studies on the metabolism of hexadecanedioic acid and its mono-L-carnitine ester. , 1973, Biochimica et biophysica acta.

[57]  K. Bloch,et al.  OMEGA-OXIDATION OF LONG CHAIN FATTY ACIDS IN RAT LIVER. , 1964, The Journal of biological chemistry.